Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/NMPA/Compound Hepar Extractum Tablets

Approved

化学药品

Compound Hepar Extractum Tablets

湖南迪博制药有限公司🇨🇳 National Medical Products Administration

Approval Date: Nov 4, 2014
Approval ID: 7LeaeIATXaZ
Company: 湖南迪博制药有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeIATXaZ
Approval Number: 国药准字H43021997
Generic Name: 复方肝浸膏片
Generic Name En: Compound Hepar Extractum Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 复方
Reg Date: 2014-11-04
Company Name: 湖南迪博制药有限公司
Production Company Address: 浏阳经济技术开发区健康大道70号
Company Detail Path: /organization/hu-nan-di-bo-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Nov 4, 2014

Approval ID

7LeaeIATXaZ

Type

化学药品

Back to NMPA Approvals

复方肝浸膏片 - NMPA Drug Approval Details